Pekka Taimen

Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer (2019)

Magnetic Resonance in Medicine

Harri Merisaari, Pekka Taimen, Rakesh Shiradkar, Otto Ettala, Marko Pesola, Jani Saunavaara, Peter J. Boström, Anant Madabhushi, Hannu J. Aronen, Ivan Jambor

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Histopathological evaluation of prostate specimens after thermal ablation may be confounded by the presence of thermally-fixed cells (2019)

International Journal of Hyperthermia

Mikael Anttinen, Eemil Yli-Pietilä, Visa Suomi, Pietari Mäkelä, Teija Sainio, Jani Saunavaara, Lauri Eklund, Roberto Blanco Sequeiros, Pekka Taimen, Peter J. Boström

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer (2019)

EJNMMI Research

Irena Saarinen, Ivan Jambor, Mai Kim, Anna Kuisma, Jukka Kemppainen, Harri Merisaari, Olli Eskola, Anna-Riina Koskenniemi, Ileana Montoya Perez, Peter Boström, Pekka Taimen, Heikki Minn

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy (2019)

Journal of Magnetic Resonance Imaging

Merisaari H., Jambor I., Ettala O., Boström P.J., Montoya Perez I., Verho J., Kiviniemi A., Syvänen K., Kähkönen E., Eklund L., Pahikkala T., Vainio P., Saunavaara J., Aronen H.J., Taimen P.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Combined inhibition of tumor suppressors PTEN and PP2A drives anoikis resistance and is associated with therapy relapse in prostate cancer (2019)

American Association for Cancer Research Annual Meeting 2019, Cancer Research

Rupp C, Isomursu A, Aakula A, Erickson A, Li SP, Kaur A, Shah P, Pokharel YR, Trottman L, Lammerding J, Rannikko A, Taimen P, Mirtti T, Paatero I, Ivaska J, Westermarck JK

(O2 Muu julkaisu )

ANO7 is associated with aggressive prostate cancer (2018)

International Journal of Cancer

Kaikkonen E., Rantapero T., Zhang Q., Taimen P., Laitinen V., Kallajoki M., Jambulingam D., Ettala O., Knaapila J., Boström P., Wahlström G., Sipeky C., Pursiheimo J., Tammela T., Kellokumpu-Lehtinen P., Fey V., Maehle L., Wiklund F., Wei G., Schleutker J.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

New prostate cancer grade grouping system predicts survival after radical prostatectomy (2018)

Human Pathology

Andrew Erickson, Kevin Sandeman, Kanerva Lahdensuo, Stig Nordling, Markku Kallajoki, Heikki Seikkula, Anna Bützow, Hanna Vasarainen, Peter J. Boström, Pekka Taimen, Antti Rannikko, Tuomas Mirtti

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice (2018)

BMC Research Notes

Christoffer Stark, Pekka Taimen, Timo Savunen, Juha Koskenvuo

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer (2018)

Endocrine-Related Cancer

Knuuttila M, Mehmood A, Maki-Jouppila J, Ryberg H, Taimen P, Knaapila J, Ettala O, Bostrom PJ, Ohlsson C, Venalainen MS, Laiho A, Elo LL, Sipila P, Makela SI, Poutanen M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

C-11-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial) (2018)

Cancer Imaging

Antti Salminen, Ivan Jambor, Harri Merisaari, Otto Ettala, Johanna Virtanen, Ilmari Koskinen, Erik Veskimae, Jukka Sairanen, Pekka Taimen, Jukka Kemppainen, Heikki Minn, Peter J. Boström

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer (2019)

Histopathological evaluation of prostate specimens after thermal ablation may be confounded by the presence of thermally-fixed cells (2019)

Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer (2019)

IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy (2019)

Combined inhibition of tumor suppressors PTEN and PP2A drives anoikis resistance and is associated with therapy relapse in prostate cancer (2019)

ANO7 is associated with aggressive prostate cancer (2018)

New prostate cancer grade grouping system predicts survival after radical prostatectomy (2018)

Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice (2018)

Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer (2018)

C-11-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial) (2018)